Frontiers in Molecular Biosciences (Dec 2016)

The mutational landscape of the oncogenic MZF1 SCAN domain in cancer

  • Mads Nygaard,
  • Thilde Terkelsen,
  • Andre Vidas Olsen,
  • Valentina Sora,
  • Juan Salamanca Viloria,
  • Fabio Rizza,
  • Sanne Bergstrand,
  • Miriam Di Marco,
  • Mette Vistesen,
  • Matteo Tiberti,
  • Matteo Lambrughi,
  • Marja Jaattela,
  • Tuula Kallunki,
  • Elena Papaleo

DOI
https://doi.org/10.3389/fmolb.2016.00078
Journal volume & issue
Vol. 3

Abstract

Read online

SCAN domains in zinc-finger transcription factors are crucial mediators of protein-protein interactions. Up to 240 SCAN-domain encoding genes have been identified throughout the human genome. These include cancer-related genes, such as the myeloid zinc finger 1 (MZF1), an oncogenic transcription factor involved in the progression of many solid cancers. The mechanisms by which SCAN homo- and heterodimers assemble and how they alter the transcriptional activity of zinc-finger transcription factors in cancer and other diseases remain to be investigated. Here, we provide the first description of the conformational ensemble of the MZF1 SCAN domain cross-validated against NMR experimental data, which are probes of structure and dynamics on different timescales. We investigated the protein-protein interaction network of MZF1 and how it is perturbed in different cancer types by the analyses of high-throughput proteomics and RNASeq data. Collectively, we integrated many computational approaches, ranging from simple empirical energy functions to all-atom microsecond molecular dynamics simulations and network analyses to unravel the effects of cancer-related substitutions in relation to MZF1 structure and interactions.

Keywords